In the case of resistance to BRAF inhibitor discussed above, IGF-1R/PI3K signaling was enhanced in resistant melanomas, and combined treatment with IGF-1R/PI3K and MEK inhibitors was tested to induce death of those resistant cells [23]. The gene discussed is IGF1R; the disease is melanoma.